The Christie Institute for Cancer Education Manchester shared a post on LinkedIn:
“Following on from our last post, we’re delighted to confirm our final speakers and reveal the rest of the faculty.
We are pleased to welcome colleagues to a UK national summit focused on Tumour-Infiltrating Lymphocyte (TIL) therapy, a potentially transformative cell-based immunotherapy that is now moving into clinical practice for melanoma.
This summit will unite UK and international experts to discuss the scientific foundations, clinical application, and operational infrastructure required to deliver TIL therapy safely and effectively. The programme will cover the entire translational pathway, from underpinning biology through to real-world clinical implementation.
We are thrilled to announce additional speakers joining an outstanding line-up for this UK national summit:
- Rebecca Lee
- Deemesh Oudit
- Samra Turajlić
- Andrew Furness
- Inge Marie Svane
- Brent O’Carrigan
Register now to secure your place at this key national event.
More to come with the full programme and session topics to be announced!”
Jonathan Lim, Co-Lead of The Manchester Immuno-Oncology Network (MION) and Lead of The Christie International Fellowship Program for Medical Oncology at The Christie NHS Foundation Trust, shared this post, adding:
“Come join us on 11th March 2026 in Manchester!”
More posts featuring The Christie NHS Foundation Trust.